Pharmacotherapy of amphetamine‐type stimulant dependence: an update
M Brensilver, KG Heinzerling… - Drug and alcohol …, 2013 - Wiley Online Library
Issues. Methamphetamine‐or amphetamine‐type stimulants are the second most frequently
used illicit drug worldwide, second only to cannabis. Behavioural treatments are efficacious …
used illicit drug worldwide, second only to cannabis. Behavioural treatments are efficacious …
Pharmacotherapy of methamphetamine addiction: an update
Methamphetamine dependence is a serious public health problem worldwide for which
there are no approved pharmacological treatments. Psychotherapy is still the mainstay of …
there are no approved pharmacological treatments. Psychotherapy is still the mainstay of …
Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review
Background Stimulant drugs are second only to cannabis as the most widely used class of
illicit drug globally, accounting for 68 million past-year consumers. Dependence on …
illicit drug globally, accounting for 68 million past-year consumers. Dependence on …
Pharmacotherapy for amphetamine dependence: A systematic review
Background Demand for treatment for amphetamine use is increasing internationally.
Establishing effective pharmacotherapy provides broader treatment options for people who …
Establishing effective pharmacotherapy provides broader treatment options for people who …
Pharmacological approaches to methamphetamine dependence: a focused review
L Karila, A Weinstein, HJ Aubin… - British journal of …, 2010 - Wiley Online Library
Methamphetamine dependence is a serious worldwide public health problem with major
medical, psychiatric, socioeconomic and legal consequences. Various neuronal …
medical, psychiatric, socioeconomic and legal consequences. Various neuronal …
Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis
Aims Addiction to methamphetamine/amphetamine (MA/A) is a major public health problem.
Currently there are no pharmacotherapies for MA/A use disorder that have been approved …
Currently there are no pharmacotherapies for MA/A use disorder that have been approved …
Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
M Bhatt, L Zielinski, L Baker-Beal, N Bhatnagar… - Systematic reviews, 2016 - Springer
Background Amphetamine and methamphetamine use disorders are associated with severe
health and social consequences. No pharmacological therapy has been approved for the …
health and social consequences. No pharmacological therapy has been approved for the …
Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of …
ME Rose, JE Grant - Annals of Clinical Psychiatry, 2008 - Taylor & Francis
Background. Methamphetamine (METH) dependence is a significant public health, criminal
justice, and social service concern, and although abuse of this drug spans the past 40 years …
justice, and social service concern, and although abuse of this drug spans the past 40 years …
Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups
E Soares, FC Pereira - Expert opinion on pharmacotherapy, 2019 - Taylor & Francis
Introduction: Drug use related deaths are increasing and the lack of effective treatment for
psychostimulants can be largely held responsible. Particularly, no pharmacotherapy is …
psychostimulants can be largely held responsible. Particularly, no pharmacotherapy is …
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
KC Morley, JL Cornish, A Faingold… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Methamphetamine use is a serious public health concern in many countries
and is second to cannabis as the most widely abused illicit drug in the world. Effective …
and is second to cannabis as the most widely abused illicit drug in the world. Effective …